How effective is Methylin for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 3.2/5 Long term ratings: 3.5/5
This is a phase IV clinical study of how effective Methylin (methylphenidate hydrochloride) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 71 Methylin users and is updated continuously.
What is Methylin?
Methylin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,116 Methylin users. Check the latest studies of Methylin.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
71 people are studied for taking Methylin in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Methylin effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 0
- somewhat: 19
- moderate: 23
- high: 23
- very high: 6
Long Term:
- not at all: 0
- somewhat: 5
- moderate: 8
- high: 14
- very high: 4
Gender of people who take Methylin for Attention deficit hyperactivity disorder *:
- female: 50.7 %
- male: 49.3 %
Age of people who take Methylin for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 9.86 %
- 10-19: 12.68 %
- 20-29: 15.49 %
- 30-39: 30.99 %
- 40-49: 12.68 %
- 50-59: 11.27 %
- 60+: 7.04 %
Who find Methylin more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Methylin for Attention deficit hyperactivity disorder *:
- female: 48.28 %
- male: 51.72 %
Age of people who take Methylin for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 6.9 %
- 10-19: 6.9 %
- 20-29: 13.79 %
- 30-39: 34.48 %
- 40-49: 13.79 %
- 50-59: 20.69 %
- 60+: 3.45 %
* Approximation only. Some reports may have incomplete information.
Do you take Methylin?
- You can start a phase IV clinical trial to monitor Methylin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Methylin (1,116 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,330 reports)
How the study uses the data?
The study is based on methylphenidate hydrochloride (the active ingredients of Methylin) and Methylin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Avandamet and Levothyroxine Sodium - 5 seconds ago
- Could Lupron cause Urinary Retention? - 5 seconds ago
- Drug interactions of Temazepam and Amphotericin B - 6 seconds ago
- Drug interactions of Cymbalta and Prozac - 10 seconds ago
- Drug interactions of Paroxetine and Ranitidine Hydrochloride - 20 seconds ago
- Evekeo vs. Focalin Xr, side effect and effectiveness comparison - 23 seconds ago
- Drug interactions of Ranitidine Hydrochloride and Mesna - 32 seconds ago
- Could Xolair cause Sciatica? - 36 seconds ago
- Could Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride cause Insomnia Exacerbated? - 38 seconds ago
- Could Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride cause Arthropathy? - 43 seconds ago